Sensus Healthcare, Inc. (SRTS)

NASDAQ: SRTS · IEX Real-Time Price · USD
3.920
-0.070 (-1.75%)
At close: Mar 27, 2024, 4:00 PM
3.960
+0.040 (1.02%)
After-hours: Mar 27, 2024, 5:06 PM EDT
-1.75%
Market Cap 65.41M
Revenue (ttm) 24.41M
Net Income (ttm) 485,000
Shares Out 16.37M
EPS (ttm) 0.03
PE Ratio 130.67
Forward PE 35.75
Dividend n/a
Ex-Dividend Date n/a
Volume 46,020
Open 3.990
Previous Close 3.990
Day's Range 3.900 - 4.020
52-Week Range 1.790 - 5.380
Beta 0.93
Analysts Strong Buy
Price Target 7.50 (+91.33%)
Earnings Date May 1, 2024

About SRTS

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which pr... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jun 3, 2016
Employees 35
Stock Exchange NASDAQ
Ticker Symbol SRTS
Full Company Profile

Financial Performance

In 2023, SRTS's revenue was $24.41 million, a decrease of -45.20% compared to the previous year's $44.53 million. Earnings were $485,000, a decrease of -98.00%.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for SRTS stock is "Strong Buy." The 12-month stock price forecast is $7.5, which is an increase of 91.33% from the latest price.

Price Target
$7.5
(91.33% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Management will discuss its new “Fair Deal Agreement” for its SRT-100 Vision™ IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th

13 days ago - GlobeNewsWire

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers

14 days ago - GlobeNewsWire

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision ™ (IG-SRT...

6 weeks ago - GlobeNewsWire

Sensus Healthcare Announces Retirement of Director Samuel O'Rear

BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effect...

7 weeks ago - GlobeNewsWire

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

BOCA RATON, Fla. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

2 months ago - GlobeNewsWire

Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million

Ships more than 60 SRT units in 2023 To report full financial results and hold conference call on February 8th

2 months ago - GlobeNewsWire

Sensus Healthcare Reports Third Quarter 2023 Financial Results

Revenues of $3.9 million reflect seasonality and macroeconomic conditions Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla.

4 months ago - GlobeNewsWire

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

BOCA RATON, Fla, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and n...

5 months ago - GlobeNewsWire

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

BOCA RATON, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effecti...

6 months ago - GlobeNewsWire

Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital

Continues SRT-100+™ customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancers Continues SRT-100+™ customer expansion to hospital oncology department...

6 months ago - GlobeNewsWire

Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego

BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effecti...

6 months ago - GlobeNewsWire

Sensus Healthcare Announces New $3 Million Share Repurchase Program

BOCA RATON, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effecti...

8 months ago - GlobeNewsWire

Sensus Healthcare Reports Second Quarter 2023 Financial Results

Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023 Achieved a milestone with the installation of 700 systems for a total of 708 Expects to ship at ...

8 months ago - GlobeNewsWire

Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023

BOCA RATON, Fla., July 26, 2023 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

8 months ago - GlobeNewsWire

Sensus Healthcare Completes Installation of its First SRT System in Ireland

Delivery of the SRT-100 marks the expansion of radiotherapy services at Dublin's Beacon Hospital Non-melanoma skin cancer affects more than 12,000 patients in Ireland annually BOCA RATON, Fla., July 2...

8 months ago - GlobeNewsWire

Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland

Full line of Sensus' SRT products for the non-invasive treatment of non-melanoma skin cancer and keloids now available to MIS Healthcare customers Full line of Sensus' SRT products for the non-invasiv...

9 months ago - GlobeNewsWire

Sensus Healthcare's SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients

BOCA RATON, Fla, May 17, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare Inc. (Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment, is ...

11 months ago - GlobeNewsWire

Sensus Healthcare Reports First Quarter 2023 Financial Results

Lower demand for SRT systems reflects the impact of inflation on dermatologists' cash flow from fewer elective aesthetic procedures and higher operating costs

11 months ago - GlobeNewsWire

Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023

BOCA RATON, Fla. , April 25, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological an...

1 year ago - GlobeNewsWire

Sensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19

New comprehensive asset and EMR management feature allows users to collect real-time information from the device to manage and maintain multiple machines with Chat GPT New comprehensive asset and EMR ...

1 year ago - GlobeNewsWire

Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million

Full-year revenues increased 65% to $44.5 million

1 year ago - GlobeNewsWire

Sensus Healthcare to Host Fourth Quarter 2022 Financial Results and Business Update Conference Call on February 9, 2023

BOCA RATON, Fla., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and ...

1 year ago - GlobeNewsWire

Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues

Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60%

1 year ago - GlobeNewsWire

Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022

BOCA RATON, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and ...

1 year ago - GlobeNewsWire

Sensus Healthcare Introduces Silk™ Laser Hair Removal System

Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical Dermatology Conference Only portable hair removal laser system with blended...

1 year ago - GlobeNewsWire